Cases 51 - 60 of 967
AbbVie Inc. v. Prinston Pharmaceutical Inc. et al
as 1:2023cv00470
Plaintiff:
AbbVie Inc.
Defendant:
Prinston Pharmaceutical Inc., Zhejiang Huahai Pharmaceutical Co., Ltd. and Solco Healthcare US, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
HARRIS et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03016
Plaintiff:
JOHN HARRIS and THE ESTATE OF PAULINE HARRIS
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MERRILL v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02857
Plaintiff:
DOUGLAS MERRILL
Defendant:
AUROBINDO PHARMA, LTD., HETERO DRUGS, LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CALDWELL v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD et al
as 1:2023cv02726
Plaintiff:
ADAM CALDWELL and DENISE CALDWELL
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, A-S MEDICATION SOLUTIONS, LLC, H J HARKINS CO., INC. and others
In Re:
VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HINES v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv02674
Plaintiff:
BRUCE HINES
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, HJ HARKINS CO., INC., HUAHAI U.S., INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
LIER v. MYLAN LABORATORIES LTD. et al
as 1:2023cv02589
Plaintiff:
HAN LIER
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WESSON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02342
Plaintiff:
EMMETT WESSON
Defendant:
AUROBINDO PHARMA LTD., HETERO DRUGS LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Valsartan Losartan and Irbesartan Products
as 23-8005
Not Classified By Court:
In re: IN RE: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Petitioner:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC, PRINSTON PHARMACEUTICAL INC and others
Respondent:
CONSUMER ECONOMIC LOSS PLAINTIFFS, THIRD-PARTY PAYOR PLAINTIFFS and MEDICAL MONITORING PLAINTIFFS
Not Yet Classified:
PRODUCT LIABILITY ADVISORY COUNCIL INC
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ZIMMERMAN et al v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv01884
Plaintiff:
Jerome Zimmerman and Trudy Zimmerman
Defendant:
Zhejiang Huahai Pharmaceutical Co., Ltd., H J HARKINS CO., INC., HUAHAI U.S. INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
